Cita APA

Burgos-Rodríguez, L. (., Puig, N. (., Cedena, M. (. T., Lahuerta, J. (. J., Paiva, B. (., & San-Miguel, J. (. F. (2020). Measurable residual disease in multiple myeloma: Ready for clinical practice?

Citación estilo Chicago

Burgos-Rodríguez, L. (Leire)|||/items/108a508a-232d-4f2a-a6b6-9031f2288606, N. (Noemí)|||/items/6ff3624a-2657-4823-b2a4-68b3f7b42ba2 Puig, M.T. (María Teresa)|||/items/d705f426-0f79-48ac-903d-b1035da55c84 Cedena, J.J. (Juan José)|||/items/fd31a0c2-8942-4d10-a5ef-df2037229340 Lahuerta, B. (Bruno)|||/items/b2c3efc5-27e1-4425-b452-efba1522c1d5 Paiva, y J.F. (Jesús F.)|||/items/114f598d-f226-4fa6-aa75-909241328543 San-Miguel. Measurable Residual Disease in Multiple Myeloma: Ready for Clinical Practice? 2020.

Cita MLA

Burgos-Rodríguez, L. (Leire)|||/items/108a508a-232d-4f2a-a6b6-9031f2288606, et al. Measurable Residual Disease in Multiple Myeloma: Ready for Clinical Practice? 2020.